BillionToOne Quarterly Income Statement
NASDAQ: BLLNHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BillionToOne revenue and earnings
In the quarter ended Jun 30, 2026, BillionToOne generated $109.4 million in revenue, up 64.4% from the same quarter a year earlier. Net income was $8.1 million, for a net margin of 7.4% versus a median of 6.2% in the prior 5 quarters. Gross margin was 70.5% (up from 65.3%) and operating margin 5.0%.
Diluted earnings per share came in at $0.15.
Summary generated from market data by MetaCap's automated system. Methodology
BillionToOne income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 109.45M | 108.39M | 96.05M | 83.52M | 66.57M | 58.96M | 45.08M | 38.42M |
| Revenue growth (YoY) | +64.40% | +83.82% | +113.09% | +117.40% | — | — | — | — |
| Cost of Revenue | 32.34M | 29.29M | 27.45M | 25.11M | 23.11M | 20.99M | 19.36M | 18.20M |
| Gross Profit | 77.11M | 79.10M | 68.60M | 58.42M | 43.47M | 37.97M | 25.72M | 20.21M |
| Operating Expenses | 71.60M | 61.26M | 58.27M | 48.78M | 45.09M | 40.29M | 37.41M | 32.85M |
| Research & Development | 17.32M | 14.69M | 14.25M | 12.95M | 11.75M | 10.43M | 11.00M | 9.55M |
| Selling, General & Admin | 54.29M | 46.57M | 44.02M | 35.83M | 33.34M | 29.86M | 26.41M | 23.30M |
| Operating Income | 5.50M | 17.83M | 10.33M | 9.63M | -1.63M | -2.31M | -11.69M | -12.63M |
| Interest Expense | 8.00K | 10.00K | 3.00K | 20.00K | 32.00K | 40.00K | 47.00K | 422.00K |
| Other Income (Expense) | 2.02M | 675.00K | -4.04M | -4.05M | 1.40M | -1.57M | 239.00K | -2.27M |
| Pretax Income | 7.52M | 18.51M | 6.30M | 5.58M | -232.00K | -3.89M | -11.45M | -14.90M |
| Income Tax | -536.00K | 539.00K | 320.00K | -129.00K | 14.50K | 100.00K | 24.00K | 0 |
| Net Income | 8.05M | 17.97M | 5.98M | 5.71M | -246.00K | -3.99M | -11.48M | -14.90M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — |
| EPS (Basic) | 0.17 | 0.39 | 0.45 | 0.14 | -0.02 | -0.39 | — | -1.47 |
| EPS (Diluted) | 0.15 | 0.34 | 0.45 | 0.10 | -0.02 | -0.39 | — | -1.47 |
| Shares Outstanding (Basic) | 46.40M | 45.93M | — | 10.43M | 10.38M | 10.31M | — | 10.11M |
| Shares Outstanding (Diluted) | 54.46M | 53.03M | — | 15.57M | 10.38M | 10.31M | — | 10.11M |
| EBITDA | 7.33M | 19.57M | 12.01M | 11.32M | 120.00K | -522.00K | -9.89M | — |
| Gross Margin | 70.45% | 72.97% | 71.42% | 69.94% | 65.29% | 64.40% | 57.06% | 52.62% |
| Operating Margin | 5.03% | 16.45% | 10.76% | 11.53% | -2.44% | -3.93% | -25.94% | -32.88% |
| Net Margin | 7.36% | 16.58% | 6.22% | 6.84% | -37.00% | -6.76% | -25.46% | -38.79% |
This table shows 8 quarterly periods of BillionToOne's income statement, from Q2 2026 back to Q3 2024, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow BLLN's reporting calendar. What is a income statement?